As the American Heart Association (AHA) rolls out its new hypertension guidelines, it has developed a 2-pronged approach for how to get the message out and drive awareness about the new guidelines and recommended lifestyle changes, explained Mary Ann Bauman, MD, of AHA.
As the American Heart Association (AHA) rolls out its new hypertension guidelines, it has developed a 2-pronged approach for how to get the message out and drive awareness about the new guidelines and recommended lifestyle changes, explained Mary Ann Bauman, MD, of AHA.
Transcript
How does the American Heart Association’s partnership with the Ad Council raise public awareness about high blood pressure?
I’m really excited about the Ad Council campaign, because what we want to do is create a sense of urgency in patients to understand that hypertension, high blood pressure, is dangerous. And even though they feel perfectly fine, the disease just marches along. So, we want to create the sense of urgency by showing people real-life people who have had the consequences of blood pressure that is not at ideal levels.
How is the American Heart Association spreading the word about the new hypertension guidelines to physicians?
We’re working with the American Medical Association to get the word out to physicians with the guidelines. We have new apps that will go to physicians to let them figure out exactly how best to handle their patients with these new guidelines. So, we’re doing a 2-pronged approached: we’re doing to patients and we’re also doing to healthcare professionals. So, everyone can start to understand what the new guidelines are and why they are so important.
Will many more people need medication under the new hypertension guidelines?
What we’re doing with the new guidelines that we don’t expect too many more people to need medication, what we really want people to understand is the lifestyle—they need to know they have high blood pressure, and then make lifestyle changes. And, then, some people will need medications, but we’re not expecting that huge numbers will.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
April 18th 2025Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Bias Reduction, Better Access Key to COVID-19 Equity Gains
April 14th 2025Interventions that target enhancing health care equity among communities disproportionately affected by the COVID-19 pandemic can be improved by including comprehensive needs assessments at the patient, provider, and health system levels.
Read More
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More